Top

Published in:

01-01-2020 | Concise Research Report

The Impact of Age on the Likely Impact of Coronary Calcium Testing in the 2018 Cholesterol Guidelines

Authors: Jeremy B. Sussman, MD, MS, Venkatesh L. Murthy, MD, PHD

Published in: Journal of General Internal Medicine | Issue 1/2020

Excerpt

The 2018 American College of Cardiology/American Heart Association cholesterol guidelines recommend substantially increasing use of coronary artery calcium testing.¹ In particular, they say it is appropriate for interested individuals aged 45 to 75 with a 10-year risk of atherosclerotic cardiovascular disease (ASCVD) between 7.5 and 20%, who do not smoke, have diabetes, or already use a statin. If a patient has a CAC of 0, the guidelines advise that statin use is not necessary. …

Available only for authorised users

Grundy SM, Stone NJ, Bailey AL, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;S0735–1097(18):39033–39038. https://doi.org/10.1016/j.jacc.2018.11.002.CrossRef

McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113(1):30–37.CrossRef

McClelland RL, Jorgensen NW, Budoff M, et al. 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). J Am Coll Cardiol. 2015;66(15):1643–1653.CrossRef

Title: The Impact of Age on the Likely Impact of Coronary Calcium Testing in the 2018 Cholesterol Guidelines
Authors: Jeremy B. Sussman, MD, MS
Venkatesh L. Murthy, MD, PHD
Publication date: 01-01-2020
Publisher: Springer US
Published in: Journal of General Internal Medicine / Issue 1/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-019-05369-w

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The Impact of Age on the Likely Impact of Coronary Calcium Testing in the 2018 Cholesterol Guidelines

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

The Role of Screening in Depression Diagnosis and Treatment in a Representative Sample of US Primary Care Visits

Awareness and Discussions About Chronic Kidney Disease Among African-Americans with Chronic Kidney Disease and Hypertension: a Mixed Methods Study

At Odds About the Odds: Women’s Choices to Accept Osteoporosis Medications Do Not Closely Agree with Physician-Set Treatment Thresholds

A Systems-Level Approach to Improving Medication Adherence in Hypertensive Latinos: a Randomized Control Trial

Telemonitoring and Team-Based Management of Glycemic Control on People with Type 2 Diabetes: a Cluster-Randomized Controlled Trial

Vitamin K Antagonist Use and Fracture

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page